Tanahun District Deploys 149 Health Workers for HPV Vaccination Campaign Against Cervical Cancer

Tanahun. A total of 149 health workers will be mobilized in Tanahun district for the HPV vaccination campaign against cervical cancer. According to Amar Dawadi, Chief of the Provincial Public Health Office, Tanahun, the vaccination campaign will be conducted by mobilizing 149 health workers across the ten local levels of the district.

The vaccination campaign will be conducted in Byas Municipality, Bhimad Municipality, Bandipur Rural Municipality, and Devghat Rural Municipality on Magh 29 and Falgun 1. Similarly, the campaign will be conducted in Bhanu Municipality, Shuklaphanta Municipality, Rishing Rural Municipality, Ghiring Rural Municipality, Myagde Rural Municipality, and Aabukhaireni Rural Municipality on Falgun 4 and 5.

Dawadi stated that 2,625 adolescent girls will be administered the HPV vaccine. The vaccine will be given to female students currently in grade 6, female students currently studying in grades 7 to 10 who were missed in the last fiscal year, 10-year-old adolescent girls who are currently not attending school, and out-of-school adolescent girls aged 11 to 14 who were missed in the last fiscal year, according to Dawadi. Last year, 14,135 adolescent girls in the district were vaccinated.

Dawadi further stated that 776 doses will be administered in Byas Municipality, 244 in Bhanu Municipality, 463 in Shuklaphanta Municipality, 258 in Bhimad Municipality, 136 in Myagde Rural Municipality, 102 in Ghiring Rural Municipality, 117 in Rishing Rural Municipality, 118 in Devghat Rural Municipality, 166 in Bandipur Rural Municipality, and 245 in Aabukhaireni Rural Municipality. It is estimated that 2,069 women in Nepal develop cervical cancer every year.

It is reported that 1,313 women die from cervical cancer every year. Cervical cancer is the second leading cause of cancer among women and the primary cause of cancer-related death among women. Health workers suggest that the HPV vaccine against cervical cancer is most effective when administered during early adolescence.